Maximum Strength Mucinex Sinus-max Severe Congestion And Pain Solution
NDC Package 63824-266-66
Package Information
Maximum Strength Mucinex Sinus-max Severe Congestion And Pain (acetaminophen, guaifenesin, and phenylephrine hydrochloride) solution is a medication used as Active ingredients (in each 20 mL) Mucinex Sinus-Max Severe Congestion & PainPurposesAcetaminophen 650mgPain relieverGuaifenesin 400 mgExpectorantPhenylephrine HCl 10 mgNasal decongestant Active ingredients (in each 20 mL)Mucinex Nightshift SinusPurposesAcetaminophen 650mgPain reliever/fever reducerDextromethorphan HBr 20 mgCough suppressantPhenylephrine HCl 10 mgNasal decongestantTriprolidine HCl 2.5 mgAntihistamine. This formulation utilizes a solution delivery system. Marketed by Reckitt Benckiser Llc, this product is identified by NDC 63824-266 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1116568 - acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution
- RxCUI: 1116568 - acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1116568 - acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 10 ML Oral Solution
- RxCUI: 1116568 - acetaminophen 650 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution
- RxCUI: 1116568 - APAP 32.5 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63824 - Reckitt Benckiser Llc
- 63824-266 - Maximum Strength Mucinex Sinus-max Severe Congestion And Pain
- 63824-266-66 - 180 mL in 1 BOTTLE
- 63824-266 - Maximum Strength Mucinex Sinus-max Severe Congestion And Pain
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63824-266-66 identifies a specific commercial package of 180 ml in 1 bottle of Maximum Strength Mucinex Sinus-max Severe Congestion And Pain, a human over the counter drug labeled by Reckitt Benckiser Llc. This solution is formulated for oral use and contains acetaminophen; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reckitt Benckiser Llc on March 01, 2018. The current certification is valid through December 31, 2027.
How is this Reckitt Benckiser Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63824026666. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.